Comparative myocardial uptake of technetium-99m sestamibi and technetium-99m tetrofosmin one hour after stress injection

European Journal of Nuclear Medicine

Volumn 25, Issue 11, 1998, Pages 1502-1510

  Gremillet, Eric ^a,b   Champailler, André ^a  

^a Centre d'Imagerie Nucleaire   (France)

^b Centre d'Imagerie Nucléaire   (France)

Author keywords

Comparison; Myocardial uptake; Technetium 99m sestamibi; Technetium 99m tetrofosmin

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTAMINATION; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYRINGE;

ADULT; AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SEX CHARACTERISTICS; STRESS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031740417     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050328     Document Type: Article

References (47)

1. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest 201-thallium/stress technetium-99m-sestamibi dual-isotope myocardial perfusion single-photon emission tomography: a clinical validation study. J Am Coll Cardiol 1993; 22: 1455-1464.
2. Weinmann P, Foult JM, Le Guludec D, et al. Dual-isotope myocardial imaging: feasibility, advantages and limitations. Preliminary report on 231 consecutive patients. Eur J Nucl Med 1994; 21:212-215.
3. 99mTc-sestamibi. Cardiol Clin 1994; 12:261-270.
4. 99mTc-methoxy-isobutyl-isonitrile (MIBI): regional and temporal activity curve analysis. Nucl Med Commun 1989; 10:723-732.
5. Faber TL, Akers MS, Peshock RM, Corbett JR. Three-dimensional motion and perfusion quantification in gated single-photon emission computed tomograms. J Nucl Med 1991; 32: 2311-2317.
6. 99mTc-MIBI. Nucl Med Commun 1992; 13:648-655.
7. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1993; 34:601-608.
8. DePuey EG, Nichols KN, Dobrinsky C. Left ventricular ejection fraction from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993; 34:1871-1876.
9. Chua T, Kiat H, Germano G, et al. Gated technetium-99m-sestamibi for simultaneous assessment of stress myocardial perfusion, post-exercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23: 1107-1114.
10. Cooke CD, Garcia EV, Cullom SJ, Faber TL, Pettigrew RI. Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med 1994; 35: 1185-1192.
11. Garcia EV. Quantitative myocardial perfusion single-photon emission computed tomographic imaging: Quo vadis? (Where do we go from here?). J Nucl Cardiol 1994; 1:83-93.
12. Goris ML, Thompson C, Malone LJ, Franken PR. Modelling the integration of myocardial regional perfusion and function. Nucl Med Commun 1994; 15:9-20.
13. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artefact. J Nucl Med 1995; 36:952-955.
14. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36:2138-2147.
15. Boonyaprapa S, Ekmahachai M, Thanachaikun N, Jaiprasert W, Sukthomya V, Poramatikul N. Measurement of left ventricular ejection fraction from gated technetium-99m sestamibi myocardial images. Eur J Nucl Med 1995; 22:528-531.
16. Berman DS, Germano G, Kiat H, Friedman J. Simultaneous perfusion/function imaging. J Nucl Cardiol 1995; 2:271-273.
17. Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996; 27:173-181.
18. Everaert H, Franken PR, Flamen P, Goris M, Momen A, Bossuyt A. Left ventricular ejection fraction from gated SPET myocardial perfusion studies: a method based on the radial distribution of count rate density across the myocardial wall. Eur J Nucl Med 1996; 23:1628-1633.
19. Ambrosio G, Betocchi S, Pace L, et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation 1996; 94:2455-2464.
20. Taillefer R, Primeau M, Costi P, Lambert R, Léveillé J, Latour Y. Technetium-99m-sestamibi myocardial imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images. J Nucl Med 1991; 32:1961-1965.
21. Franceschi M, Guimond J, Zimmerman RE, et al. Myocardial clearance of Tc-99 m hexakis-2-methoxypropyl isonotrile (MIBI) in patients with coronary artery disease. Clin Nucl Med 1990; 15:307-312.
22. Richter WS, Cordes M, Calder D, Eichstaedt H, Felix R. Washout and redistribution between immediate and two-hour myocardial images using technetium-99m sestamibi. Eur J Nucl Med 1995; 22:49-55.
23. Flamen P, Bossuyt A, Franken PR. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995; 36:2009-2015.
24. Naruse H, Daher E, Sinusas A, et al. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin. J Nucl Med 1996; 37:1783-1788.
25. Valkema R, de Jong M, Reijs AEM, van Peski J, Krenning EP. Myocardial uptake of Tc-99m-tetrofosmin and Tc-99m-mibi [abstract]. J Nucl Med 1996; 37:48P.
26. Munch G, Neverve J, Matsunari I, Schröter G, Schwaiger M. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med 1997; 38:428-432.
27. Widding A, Hesse B, Gadsboll N. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base ? Eur J Nucl Med 1997; 24:42-45.
28. Gremillet E, Champailler A. Tomoscintigraphie myocardique séquentielle double isotope avec synchronisation à l'ECG: justification théorique et réalisation pratique. Médecine Nucléaire 1997; 21:137-141.
29. Gremillet E, Champailler A, Wartski M, Blasco A, Guillot S. Heart motion correction in myocardial SPECT with a 90° dual-head camera. [abstract]. Eur J Nucl Med 1996; 23:1122.
30. Germano G, Erel J, Kiat H, Kvanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997; 38:749-754.
31. Maunoury C, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT. J Nucl Med 1997; 38:958-961.
32. Galt JR, Garcia EV, Robbins W. Effects of myocardial wall thickness on SPECT quantification. IEEE Trans Med Imaging 1990; 9:144-150.
33. Buvat I, Bartlett ML, Kitsiou AN, Dilsizian V, Bacharach SL. A $hybrid" method for measuring myocardial wall thickening from gated PET/SPECT images. J Nucl Med 1997; 38: 324-329.
34. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artefacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994; 35:356-359.
35. Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L. A study of the liver-heart artefact in emission tomography. J Nucl Med 1995; 36:133-139.
36. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human distribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
37. Savi A, Gerundini P, Zoli P, et al. Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med 1989; 15:597-600.
38. Taillefer R. Technetium-99m sestamibi myocardial imaging same day rest-stress studies and dipyridamole. Am J Cardiol 1990; 66:80E-84E.
39. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34:1254-1259.
40. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34:30-38.
41. 99mTc-tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun 1995; 16:733-740.
42. Matsunari I, Tanishima Y, Taki J, et al. Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med 1996; 37:1622-1626.
43. Villanueva-Meyer J, Mena I, Diggles L, Narahara KA. Assessment of myocardial perfusion defect size after early and delayed SPECT imaging with technetium-99m-hexakis 2-methoxyisobutyl isonitrile after stress. J Nucl Med 1993; 34: 187-192.
44. 18F]fluorodeoxyglucose. Circulation 1994; 89:578-587 [erratum in Circulation 1995; 91:3026].
45. Maurea S, Cuocolo A, Soricelli A, et al. Myocardial viability index in chronic artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995; 36:1953-1960.
46. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37:1289-1294.
47. Lipiecki J, Bourgeois V, Maublant J, et al. Predictive value of rest-redistribution Tc-99m-tetrofosmin SPECT in the detection of residual viability in the territory of infarct related artery in the late phase of MI [abstract]. J Am Coll Cardiol 1997; 29:1652.